Literature DB >> 2140389

Decreased HLA-DR antigen expression on monocytes causes impaired suppressor cell activity in multiple sclerosis.

C N Baxevanis1, G J Reclos, M Papamichail.   

Abstract

Mitogen-induced Ts cell activity and (DR) expression on monocytes have recently been shown to be reduced in patients with multiple sclerosis (MS). In our study, T cells were cultured with autologous monocytes in the presence of Con A for 6 days (primary cultures). At the end of the culture T cells were isolated and were 1) tested for surface DR expression and 2) treated with mitomycin C and placed in a secondary culture of allogeneic responder cells and Con A, to test their suppressor function. Treatment of monocytes of the primary culture with an anti-HLA-DR antibody abolished the expression of DR Ag on the T cells as well as their ability to function as Ts cells in the secondary culture. Monocytes from patients with active MS expressed low levels of surface DR Ag and induced reduced amounts of DR Ag on the surface of autologous T cells in primary cultures, which in turn expressed deficient suppressor function when placed in secondary cultures. In contrast, monocytes obtained from patients with inactive disease expressed higher levels of DR and induced higher amounts of DR Ag on autologous T cells, which expressed normal suppressor function. We conclude that the deficient expression of DR Ag on MS monocytes causes reduced suppressor function in activated autologous T cells and may be a primary abnormality in the immunopathogenesis of MS.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2140389

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Promotion of murine antitumor activity by prothymosin alpha treatment: I. Induction of tumoricidal peritoneal cells producing high levels of tumour necrosis factor alpha.

Authors:  M Papanastasiou; C N Baxevanis; M Papamichail
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

2.  Decreased expression of adhesion molecules on monocytes in recent onset IDDM.

Authors:  S Martin; H Rothe; D Tschöpe; B Schwippert; H Kolb
Journal:  Immunology       Date:  1991-05       Impact factor: 7.397

3.  Induction of tumor-specific T lymphocyte responses in vivo by prothymosin alpha.

Authors:  C N Baxevanis; A D Gritzapis; G Spanakos; O E Tsitsilonis; M Papamichail
Journal:  Cancer Immunol Immunother       Date:  1995-06       Impact factor: 6.968

4.  Induction of lymphokine-activated killer activity in mice by prothymosin alpha.

Authors:  C N Baxevanis; A D Gritzapis; G V Dedoussis; N G Papadopoulos; O Tsolas; M Papamichail
Journal:  Cancer Immunol Immunother       Date:  1994-04       Impact factor: 6.968

5.  Inhibition of T cell responses by activated human CD8+ T cells is mediated by interferon-gamma and is defective in chronic progressive multiple sclerosis.

Authors:  K E Balashov; S J Khoury; D A Hafler; H L Weiner
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

6.  Cytotoxic T-cell precursor frequencies to HER-2 (369-377) in patients with HER-2/neu-positive epithelial tumours.

Authors:  P A Sotiropoulou; S A Perez; E G Iliopoulou; I Missitzis; V Voelter; H Echner; C N Baxevanis; M Papamichail
Journal:  Br J Cancer       Date:  2003-09-15       Impact factor: 7.640

7.  Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes.

Authors:  N Tsavaris; C Kosmas; M Vadiaka; P Kanelopoulos; D Boulamatsis
Journal:  Br J Cancer       Date:  2002-07-01       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.